ResearcherOsaka International Cancer InstituteActive in the last 2 years
Kana Hosokawa
Matched on OpenAlex author ID A5011964999. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2023: 1 paper · 2024: 2 papers · 2025: 2 papers · 2026: 2 papers
Papers 7
- Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment. Co-author DOI 10.1002/cnr2.70492↗
- Effects of Pancreatic Duct Stenting on Nutrition and Pancreatic Function in Unresectable Pancreatic Cancer: A Pilot Study. Co-author DOI 10.1002/jgh3.70358↗
- Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer. Co-author DOI 10.1007/s12029-025-01309-6↗
- Impact of zinc deficiency on the prognosis of unresectable pancreatic cancer. Co-author DOI 10.1016/j.pan.2025.05.007↗
- Impact of cancer cachexia on survival in patients with pancreatic cancer and the efficacy of first-line chemotherapy. First author DOI 10.1007/s10147-024-02564-6↗
- Impact of time from diagnosis to chemotherapy on prognosis in advanced pancreatic cancer. Co-author DOI 10.1093/jjco/hyae027↗
- Impact of Initial Body Weight Loss on Prognosis in Advanced Pancreatic Cancer: Insights From a Single-Center Retrospective Study. Co-author DOI 10.1177/10732748231204719↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kenji Ikezawa · 4 shared papers, 2025–2026 · strength 0.96
- Paper Effects of Pancreatic Duct Stenting on Nutrition and Pancreatic Function in Unresectable Pancreatic Cancer: A Pilot Stu… DOI 10.1002/jgh3.70358↗
- Paper Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the… DOI 10.1002/cnr2.70492↗
- Paper Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer. DOI 10.1007/s12029-025-01309-6↗
- Ryoji Takada · 4 shared papers, 2025–2026 · strength 0.96
- Paper Effects of Pancreatic Duct Stenting on Nutrition and Pancreatic Function in Unresectable Pancreatic Cancer: A Pilot Stu… DOI 10.1002/jgh3.70358↗
- Paper Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the… DOI 10.1002/cnr2.70492↗
- Paper Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer. DOI 10.1007/s12029-025-01309-6↗
- Yugo Kai · 4 shared papers, 2025–2026 · strength 0.96
- Paper Effects of Pancreatic Duct Stenting on Nutrition and Pancreatic Function in Unresectable Pancreatic Cancer: A Pilot Stu… DOI 10.1002/jgh3.70358↗
- Paper Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the… DOI 10.1002/cnr2.70492↗
- Paper Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer. DOI 10.1007/s12029-025-01309-6↗
- Makiko Urabe · 4 shared papers, 2025–2026 · strength 0.96
- Paper Effects of Pancreatic Duct Stenting on Nutrition and Pancreatic Function in Unresectable Pancreatic Cancer: A Pilot Stu… DOI 10.1002/jgh3.70358↗
- Paper Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the… DOI 10.1002/cnr2.70492↗
- Paper Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer. DOI 10.1007/s12029-025-01309-6↗
- Kazuyoshi Ohkawa · 4 shared papers, 2025–2026 · strength 0.96
- Paper Effects of Pancreatic Duct Stenting on Nutrition and Pancreatic Function in Unresectable Pancreatic Cancer: A Pilot Stu… DOI 10.1002/jgh3.70358↗
- Paper Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the… DOI 10.1002/cnr2.70492↗
- Paper Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer. DOI 10.1007/s12029-025-01309-6↗
- Aya Sugimoto · 3 shared papers, 2023–2024 · strength 0.73
- Paper Impact of cancer cachexia on survival in patients with pancreatic cancer and the efficacy of first-line chemotherapy. DOI 10.1007/s10147-024-02564-6↗
- Paper Impact of time from diagnosis to chemotherapy on prognosis in advanced pancreatic cancer. DOI 10.1093/jjco/hyae027↗
- Paper Impact of Initial Body Weight Loss on Prognosis in Advanced Pancreatic Cancer: Insights From a Single-Center Retrospect… DOI 10.1177/10732748231204719↗
- Tsutomu Nishida · 3 shared papers, 2023–2024 · strength 0.73
- Paper Impact of cancer cachexia on survival in patients with pancreatic cancer and the efficacy of first-line chemotherapy. DOI 10.1007/s10147-024-02564-6↗
- Paper Impact of time from diagnosis to chemotherapy on prognosis in advanced pancreatic cancer. DOI 10.1093/jjco/hyae027↗
- Paper Impact of Initial Body Weight Loss on Prognosis in Advanced Pancreatic Cancer: Insights From a Single-Center Retrospect… DOI 10.1177/10732748231204719↗
- Ko Watsuji · 2 shared papers, 2025–2026 · strength 0.49
- Yusuke Seiki · 2 shared papers, 2025–2026 · strength 0.49
- Takumi Kinomoto · 2 shared papers, 2025–2026 · strength 0.47
- Paper Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the… DOI 10.1002/cnr2.70492↗
- Paper Clinical Outcome and Safety of Triweekly Modified FOLFIRINOX Therapy in Patients with Advanced Pancreatic Cancer. DOI 10.1007/s12029-025-01309-6↗
- Kengo Matsumoto · 2 shared papers, 2023–2024 · strength 0.37
- Koji Fukui · 2 shared papers, 2023–2024 · strength 0.37
- Naohiro Sakamoto · 1 shared paper, 2023 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.